JPMorgan Chase & Co’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | -$4 | – | 6472 |
|
|
2024
Q2 | – | Hold |
0
| – | -$6 | – | 6230 |
|
|
2024
Q1 | – | Hold |
0
| – | -$12 | – | 6254 |
|
|
2023
Q4 | – | Hold |
0
| – | -$4 | – | 6367 |
|
|
2023
Q3 | – | Sell |
-3
| Closed | -$93 | – | 6416 |
|
|
2023
Q2 | $93 | Buy |
+3
| New | +$93 | ﹤0.01% | 5792 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6067 |
|
|
2022
Q4 | – | Sell |
-3
| Closed | -$1K | – | 5863 |
|
|
2022
Q3 | $1K | Buy |
3
+1
| +50% | +$333 | ﹤0.01% | 5440 |
|
|
2022
Q2 | $2K | Sell |
2
-4
| -67% | -$4K | ﹤0.01% | 5422 |
|
|
2022
Q1 | $15K | Buy |
6
+1
| +20% | +$2.5K | ﹤0.01% | 5316 |
|
|
2021
Q4 | $12K | Sell |
5
-41
| -89% | -$98.4K | ﹤0.01% | 5409 |
|
|
2021
Q3 | $209K | Buy |
46
+44
| +2,200% | +$200K | ﹤0.01% | 4390 |
|
|
2021
Q2 | $13K | Sell |
2
-57
| -97% | -$371K | ﹤0.01% | 5182 |
|
|
2021
Q1 | $434K | Buy |
+59
| New | +$434K | ﹤0.01% | 4109 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5055 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | -$4K | – | 4914 |
|
|
2019
Q1 | $4K | Buy |
+1
| New | +$4K | ﹤0.01% | 4721 |
|
|
2018
Q4 | – | Sell |
-74
| Closed | -$652K | – | 4954 |
|
|
2018
Q3 | $652K | Buy |
74
+28
| +61% | +$247K | ﹤0.01% | 3376 |
|
|
2018
Q2 | $390K | Buy |
+46
| New | +$390K | ﹤0.01% | 3557 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | -$4K | – | 4771 |
|
|
2017
Q4 | $4K | Sell |
1
-4
| -80% | -$16K | ﹤0.01% | 4569 |
|
|
2017
Q3 | $55K | Buy |
+5
| New | +$55K | ﹤0.01% | 3783 |
|